News
2seventy bio Adds Eli Casdin And Charles Newton To Board
20 Mar 24
News, Management
Why Science Applications International Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
18 Mar 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
FDA Adcomm Favors Expanded Use Of Johnson & Johnson, Bristol Myers' CAR-T Therapies For Type Of Blood Cancer
18 Mar 24
Biotech, Large Cap, News, Health Care, FDA, Movers, Trading Ideas, General
Market-Moving News for March 18th
18 Mar 24
Movers, Trading Ideas
Wedbush Reiterates Neutral on 2seventy bio, Maintains $5 Price Target
18 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Reported Saturday, FDA Advisory Committee Votes In Favor Of Bristol Myers Squibb's And 2seventy Bio's Abecma For Triple-Class Exposed Multiple Myeloma In Earlier Lines Of Therapy
18 Mar 24
News
Why Cardlytics Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
15 Mar 24
News, Penny Stocks, Small Cap, Pre-Market Outlook, Markets, Movers, Trading Ideas
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
7 Mar 24
Analyst Color, Biotech, News, Health Care, Initiation, Analyst Ratings, Movers, Trading Ideas, General
2seventy bio Q4 EPS $(1.11) Misses $(0.99) Estimate, Sales $10.68M Miss $14.71M Estimate
5 Mar 24
Earnings, News
Earnings Scheduled For March 5, 2024
5 Mar 24
Earnings
A Preview Of 2seventy bio's Earnings
4 Mar 24
Earnings
Why Is Sanofi Partner Regeneron Pharmaceuticals Stock Trading Higher Today?
2 Feb 24
Biotech, Earnings, Large Cap, News, Guidance, Health Care, Movers, Trading Ideas, General
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
31 Jan 24
News, Penny Stocks, Small Cap, Intraday Update, Markets, Movers, Trading Ideas
12 Health Care Stocks Moving In Wednesday's Intraday Session
31 Jan 24
Movers
Crude Oil Down 2%; Alphabet Shares Fall After Q4 Results
31 Jan 24
Earnings, News, Penny Stocks, Eurozone, Commodities, Small Cap, Global, Intraday Update, Markets, Trading Ideas
Leerink Partners Upgrades 2seventy bio to Outperform, Raises Price Target to $18
31 Jan 24
News, Upgrades, Price Target, Analyst Ratings
TD Cowen Downgrades 2seventy bio to Market Perform
31 Jan 24
News, Downgrades, Analyst Ratings
12 Health Care Stocks Moving In Tuesday's Intraday Session
30 Jan 24
Movers
2seventy bio Names Chip Baird, Its COO, To Become CEO; Nick Leschly Named Incoming Chairman Of Board
30 Jan 24
News, Management
FDA Reported Monday It Is Requiring Boxed Warning For CAR-T Cancer Therapies
23 Jan 24
News, FDA
Press releases
2seventy bio Announces Appointments of Eli Casdin and Charles Newton to Board of Directors
20 Mar 24
Press Releases
FDA Advisory Committee Votes in Favor of Bristol Myers Squibb's and 2seventy bio's Abecma for Triple-Class Exposed Multiple Myeloma in Earlier Lines of Therapy
15 Mar 24
Press Releases
2seventy bio to Report Fourth Quarter and Full Year 2023 Financial Results and Participate in Upcoming Investor Conferences
1 Mar 24
Press Releases
2seventy bio to Participate in Upcoming Investor Conferences
5 Feb 24
Press Releases
Bristol Myers Squibb and 2seventy bio Share Update on U.S. FDA Oncologic Drugs Advisory Committee Meeting for Abecma in Triple-Class Exposed Multiple Myeloma Based on KarMMa-3 Study
5 Feb 24
Press Releases
Biotech Shares Soar Premarket On Sale Of R&D Assets
30 Jan 24
2seventy bio Announces New Strategic Path Forward
30 Jan 24
Press Releases